Temsirolimus Side Effects Temsirolimus Reviews: View Temsirolimus Adverse Event Reports: patient, 15 years of age, weighting 116.4 lb, was diagnosed with lymphoma and took Temsirolimus 35 Mg/m2, Iv Patient was hospitalized.

Have Your experienced Temsirolimus Side Effects? You are not alone. Many patients report unusual symptoms after using Temsirolimus. This forum raises awareness about Temsirolimus Side Effects.

side effects
Home> Temsirolimus> Temsirolimus Side Effects
What Are Your Temsirolimus Side Effects
Edema (1)
>>See All

Common Temsirolimus Side Effects

top 5 Temsirolimus|Edema adverse effects

Before Taking Temsirolimus

Find Out How to Take Temsirolimus

Managing Your Medicines

Tips for Taking Medicines Properly

Did You Have a Temsirolimus Side Effect?

Yes, Severe
Yes, Moderate
Yes, Minor
No

How Effective is Temsirolimus for You?

Exceeded Expectations
Effective
Somewhat Effective
Not Effective

Temsirolimus Forum

Temsirolimus Adverse Effect Reports (FDA)

Enter Unusual Symptoms or Side Effects:

Showing 1-25 of 1065 

Cough, Snoring, Blood Ph Decreased, Hypercapnia, Dyspnoea, Forced Expiratory Volume Decreased, Pco2 Increased, Blood Bicarbonate Increased (8482963-0)
on Jun 18, 2012 Female patient from UNITED STATES , 15 years of age, weighting 116.4 lb, was diagnosed with and was treated with Temsirolimus(View Usage). Patient experienced the following unwanted or unexpected effects: cough, snoring (snoring Questions), blood ph decreased, hypercapnia, dyspnoea, forced expiratory volume decreased, pco2 increased, blood bicarbonate increased. Temsirolimus dosage: 35 Mg/m2, Iv.
Patient was taking other medications: Patient was hospitalized.

Humerus Fracture (8475894-3)
Patient was taking Temsirolimus (View Usage). Patient had the following side effects: humerus fracture on Jun 21, 2012 from JAPAN Additional patient health information: Female patient , 78 years of age, weighting 132.3 lb, was diagnosed with
  • metastatic renal cell carcinoma
and. Temsirolimus dosage: 25 Mg, Weekly.
Patient was taking other medications: Patient was hospitalized.

Stomatitis, Platelet Count Decreased (8470674-7)
Adverse event was reported on Jun 20, 2012 by a Male patient taking Temsirolimus (View Usage) (Dosage: 15 Mg, Unk) was diagnosed with
  • metastatic renal cell carcinoma
  • prophylaxis
and. Location: JAPAN , 67 years of age, weighting 111.6 lb, After Temsirolimus was administered, patient had the following side effects: stomatitis, platelet count decreased.
Patient was taking other medications:

Pneumothorax, Pleuritic Pain, Dyspnoea (8468179-2)
on Jun 15, 2012 Female patient from UNITED STATES , weighting 126.1 lb, was diagnosed with
  • renal cell carcinoma
and was treated with Temsirolimus (View Usage). Patient experienced the following unwanted or unexpected effects: pneumothorax, pleuritic pain, dyspnoea. Temsirolimus dosage: N/A.
Patient was taking other medications: Patient was hospitalized.


Osteonecrosis, Cluster Headache, Pelvic Pain, Diabetes Mellitus, Arthralgia (8459433-9)
on Jun 18, 2012 Male patient from CANADA , weighting 211.6 lb, was diagnosed with
  • metastatic renal cell carcinoma
and was treated with Temsirolimus(View Usage). Patient had the following side effects: osteonecrosis (osteonecrosis Questions), cluster headache, pelvic pain (pelvic pain Questions), diabetes mellitus, arthralgia. Temsirolimus dosage: 25 Mg, Weekly.
Patient was taking other medications: Patient was hospitalized.

Sinusitis (8454081-9)
Patient was taking Temsirolimus (View Usage). After Temsirolimus was administered, patient had the following side effects: sinusitis (sinusitis Questions) on Jun 13, 2012 from POLAND Additional patient health information: Male patient , 57 years of age, . Temsirolimus dosage: 25 Mg, Unk. Patient was hospitalized.

Dyspnoea, Atrial Fibrillation, Fatigue, Renal Failure Acute, Urinary Tract Infection (8447610-2)
Adverse event was reported on Jun 08, 2012 by a Male patient taking Temsirolimus (View Usage) (Dosage: 25 Mg, Weekly) was diagnosed with
  • mantle cell lymphoma
and. Location: UNITED STATES , weighting 225.1 lb, Patient experienced the following unwanted or unexpected effects: dyspnoea, atrial fibrillation (atrial fibrillation Questions), fatigue, renal failure acute, urinary tract infection (urinary tract infection Questions).
Patient was taking other medications: Patient was hospitalized.

Anal Ulcer (8439668-1)
on Jun 06, 2012 Male patient from UNITED STATES , child 10 years of age, weighting 109.3 lb, was diagnosed with
  • b precursor type acute leukaemia
and was treated with Temsirolimus (View Usage). Patient had the following side effects: anal ulcer. Temsirolimus dosage: 7.5 Mg/m2, Over 30 Minutes On Days 1, 8 And 15 (max Dose: 15 Mg).
Patient was taking other medications: Patient was hospitalized.

Dyspnoea, Renal Failure Acute, Urinary Tract Infection, Atrial Fibrillation, Fatigue (8437234-5)
on Jun 08, 2012 Male patient from UNITED STATES , weighting 225.1 lb, was diagnosed with
  • mantle cell lymphoma
and was treated with Temsirolimus(View Usage). After Temsirolimus was administered, patient had the following side effects: dyspnoea, renal failure acute, urinary tract infection (urinary tract infection Questions), atrial fibrillation (atrial fibrillation Questions), fatigue. Temsirolimus dosage: 25 Mg, Weekly.
Patient was taking other medications: Patient was hospitalized.

Atelectasis, Febrile Neutropenia, Pneumonitis, Hypokalaemia, Pleural Effusion, Hypotension, Hypoxia (8429018-9)
Patient was taking Temsirolimus (View Usage). Patient experienced the following unwanted or unexpected effects: atelectasis, febrile neutropenia, pneumonitis, hypokalaemia, pleural effusion, hypotension, hypoxia on Jun 07, 2012 from UNITED STATES Additional patient health information: Female patient , 14 years of age, weighting 121.3 lb, was diagnosed with
  • rhabdomyosarcoma
and. Temsirolimus dosage: 15 Mg/m2, Over 30-60 Minutes On Days 1, 8 And 15.
Patient was taking other medications: Patient was hospitalized.

Atrial Fibrillation, Fatigue, Renal Failure Acute, Dyspnoea, Urinary Tract Infection (8423599-7)
Adverse event was reported on Jun 01, 2012 by a Male patient taking Temsirolimus (View Usage) (Dosage: 25 Mg, Weekly) was diagnosed with
  • mantle cell lymphoma
and. Location: UNITED STATES , weighting 224.0 lb, Patient had the following side effects: atrial fibrillation (atrial fibrillation Questions), fatigue, renal failure acute, dyspnoea, urinary tract infection (urinary tract infection Questions).
Patient was taking other medications: Patient was hospitalized.

Depressed Level Of Consciousness (8421528-3)
on May 16, 2012 Male patient from FRANCE , 74 years of age, was diagnosed with
  • glioblastoma
and was treated with Temsirolimus (View Usage). After Temsirolimus was administered, patient had the following side effects: depressed level of consciousness. Temsirolimus dosage: 25 Mg Milligram(s), 1 In 1 Wk, Otherwise Specified).
Patient was taking other medications:

Hypoxia (8420885-1)
on Jun 04, 2012 Female patient from JAPAN , 64 years of age, weighting 110.2 lb, was diagnosed with
  • renal cell carcinoma
and was treated with Temsirolimus(View Usage). Patient experienced the following unwanted or unexpected effects: hypoxia. Temsirolimus dosage: 25 Mg, Weekly.
Patient was taking other medications: Patient was hospitalized.

Pneumonitis, Atelectasis, Febrile Neutropenia, Hypoxia, Hypotension, Hypokalaemia, Pleural Effusion (8419951-6)
Patient was taking Temsirolimus (View Usage). Patient had the following side effects: pneumonitis, atelectasis, febrile neutropenia, hypoxia, hypotension, hypokalaemia, pleural effusion on May 30, 2012 from UNITED STATES Additional patient health information: Female patient , 14 years of age, weighting 121.3 lb, was diagnosed with
  • rhabdomyosarcoma
and. Temsirolimus dosage: Days 1, 8 And 15 Over 30-60 Minutes.
Patient was taking other medications: Patient was hospitalized.

Disease Progression, Renal Cell Carcinoma (8418669-3)
Adverse event was reported on Jun 05, 2012 by a Female patient taking Temsirolimus (View Usage) (Dosage: 25 Mg, Weekly) . Location: JAPAN , 62 years of age, weighting 90.39 lb, After Temsirolimus was administered, patient had the following side effects: disease progression, renal cell carcinoma.

Urinary Tract Infection, Dyspnoea, Renal Failure Acute, Atrial Fibrillation, Fatigue (8414925-3)
on Jun 01, 2012 Male patient from UNITED STATES , 66 years of age, weighting 224.0 lb, was diagnosed with
  • mantle cell lymphoma
and was treated with Temsirolimus (View Usage). Patient experienced the following unwanted or unexpected effects: urinary tract infection (urinary tract infection Questions), dyspnoea, renal failure acute, atrial fibrillation (atrial fibrillation Questions), fatigue. Temsirolimus dosage: 25mg Weekly Iv Drip.
Patient was taking other medications: Patient was hospitalized.

Pneumocystis Jiroveci Pneumonia (8406933-3)
on Jun 04, 2012 Male patient from JAPAN , 57 years of age, was diagnosed with
  • metastatic renal cell carcinoma
and was treated with Temsirolimus(View Usage). Patient had the following side effects: pneumocystis jiroveci pneumonia. Temsirolimus dosage: 25 Mg, Cyclic, Weekly.

Systemic Inflammatory Response Syndrome, Rash (8404730-6)
Patient was taking Temsirolimus (View Usage). After Temsirolimus was administered, patient had the following side effects: systemic inflammatory response syndrome, rash (rash Questions) on May 31, 2012 from SWITZERLAND Additional patient health information: Male patient , 55 years of age, weighting 220.5 lb, was diagnosed with
  • glioblastoma
and. Temsirolimus dosage: 25 Mg, Weekly.
Patient was taking other medications: Patient was hospitalized.

Pneumonia Bacterial, Interstitial Lung Disease (8402001-5)
Adverse event was reported on May 30, 2012 by a Male patient taking Temsirolimus (View Usage) (Dosage: 25 Mg, Unk) . Location: JAPAN , 68 years of age, weighting 79.37 lb, Patient experienced the following unwanted or unexpected effects: pneumonia bacterial, interstitial lung disease.
Patient was taking other medications: Patient was hospitalized.

Pulmonary Embolism, Deep Vein Thrombosis, Pneumothorax (8401938-0)
on May 24, 2012 Male patient from GERMANY , weighting 176.4 lb, was diagnosed with
  • metastatic renal cell carcinoma
and was treated with Temsirolimus (View Usage). Patient had the following side effects: pulmonary embolism (pulmonary embolism Questions), deep vein thrombosis (deep vein thrombosis Questions), pneumothorax. Temsirolimus dosage: Unk.
Patient was taking other medications: Patient was hospitalized and became disabled.

Sinusitis (8396496-3)
on May 28, 2012 Male patient from POLAND , 57 years of age, was treated with Temsirolimus(View Usage). After Temsirolimus was administered, patient had the following side effects: sinusitis (sinusitis Questions). Temsirolimus dosage: 50 Mg, Unk. Patient was hospitalized.

Cardiac Arrest (8396483-5)
Patient was taking Temsirolimus (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac arrest (cardiac arrest Questions) on May 22, 2012 from UNITED STATES Additional patient health information: Male patient , 67 years of age, weighting 110.0 lb, . Temsirolimus dosage: 20 Mg, On Days 1,8, 15, 22 Of Each 28 Days Cycle.
Patient was taking other medications: Patient was hospitalized.

Dyspnoea (8395290-7)
Adverse event was reported on May 24, 2012 by a Male patient taking Temsirolimus (View Usage) (Dosage: 12.5 Mg, Unk) . Location: JAPAN , 83 years of age, weighting 132.3 lb, Patient had the following side effects: dyspnoea.
Patient was taking other medications: Patient was hospitalized.

Decreased Appetite, Weight Decreased, Nausea, Sepsis, Dyspnoea, Ascites (8392985-6)
on May 23, 2012 Male patient from GERMANY , 60 years of age, weighting 152.1 lb, was diagnosed with
  • renal cancer
and was treated with Temsirolimus (View Usage). After Temsirolimus was administered, patient had the following side effects: decreased appetite, weight decreased, nausea (nausea Questions), sepsis (sepsis Questions), dyspnoea, ascites. Temsirolimus dosage: 25 Mg, Unk.
Patient was taking other medications: Patient was hospitalized.

Hyperlipidaemia, Interstitial Lung Disease, Dyspnoea, Renal Impairment, Anaemia (8384733-0)
on May 15, 2012 Male patient from TAIWAN, PROVINCE OF CHINA , 57 years of age, was diagnosed with
  • metastatic renal cell carcinoma
and was treated with Temsirolimus(View Usage). Patient experienced the following unwanted or unexpected effects: hyperlipidaemia, interstitial lung disease, dyspnoea, renal impairment, anaemia. Temsirolimus dosage: N/A.

Showing 1-25 of 1065 

Share Your Experience, Discuss with Others

Temsirolimus Information

More About Temsirolimus

Side Effects reported to FDA: 1065. View FDA Adverse Reports

Temsirolimus safety alerts: No

Reported deaths: 238

Reported hospitalizations: 776

1Edema
View More

Ask a Doctor


13 Doctors are Online Now. Current Wait time: 7 Minutes

View Temsirolimus Use Reports

What do You think about Temsirolimus? Join the discussion!

blog comments powered by Disqus

Medicines have benefits and risks. The risks are the chances that something unwanted or unexpected could happen to you when you use them. You can protect yourself by searching summaries of recent safety Temsirolimus alerts and medication adverse reports. Search for documented Temsirolimus side effects on the label or the drug's package insert. You may also want to speak with your pharmacist or healthcare provider. Sometimes there are risks that only come to light after a medical product gets on the market and is used in a larger number of patients, for a longer period of time, and in patients whose health characteristics are different from those of the patients studied before approval.

Go to the top of the page
further research and contacting my doctor

When did you start feeling unusual symptoms? what was the first symptom? Did your symptoms get worse over time? Did you have similar symptoms before using Temsirolimus? What did Your doctor say? Share Your Story

> Medical Devices

Reply to Temsirolimus Questions, Answers, Feedback and Comments

No comments have been provided.

Temsirolimus Adverse Reactions
Dyspnoea ( 63 Reports)
Pneumonia ( 62 Reports) Pneumonia Questions
Diarrhoea ( 57 Reports)
Disease Progression ( 57 Reports)
Pyrexia ( 56 Reports)
Anaemia ( 49 Reports)
Dehydration ( 48 Reports)
Vomiting ( 43 Reports)
Death ( 42 Reports)
Fatigue ( 42 Reports)
Nausea ( 36 Reports) Nausea Questions
Pleural Effusion ( 36 Reports)
Interstitial Lung Disease ( 33 Reports)
Sepsis ( 31 Reports) Sepsis Questions
Deep Vein Thrombosis ( 29 Reports) Deep vein thrombosis Questions
Hyperglycaemia ( 28 Reports)
Haemoglobin Decreased ( 27 Reports)
Renal Cell Carcinoma ( 26 Reports)
Asthenia ( 24 Reports)
Pneumonitis ( 24 Reports)
Renal Failure ( 24 Reports)
Condition Aggravated ( 22 Reports)
Decreased Appetite ( 22 Reports)
Febrile Neutropenia ( 22 Reports)
Hyponatraemia ( 22 Reports)
Respiratory Failure ( 22 Reports)
Blood Creatinine Increased ( 21 Reports)
Abdominal Pain ( 20 Reports) Abdominal pain Questions
Headache ( 20 Reports) Headache Questions
Hypokalaemia ( 20 Reports)

Often additional risks of using a medication, such as Temsirolimus, become known after product is used by a larger number of patients, for a longer period of time, and by patients with different health characteristics from those studied before drug approval. This page allows You to Find answers and discuss health symptoms with other Temsirolimus users, Learn more about unwanted side effects & find ways to reduce them. Browse Temsirolimus Adverse Reports reported to FDA and participate in Temsirolimus discussion, find alternative treatments and find ways to avoid or reduce risks associated with using Temsirolimus. You can also Post a question to users community or Ask a Doctor. PatientsVille.com is Your Complete Guide to all common, undocumented and undisclosed side effects associated with drugs and vaccines.

Be aware of the following potential Temsirolimus risks:

  • Watch for any Serious adverse events, such as life-threatening situation, which can require an admission to hospital or longer-than-expected hospital stay, permanent disability, birth defect, miscarriage, stillbirth, or birth with serious disease requires medical care to prevent permanent damage
  • Any potential Temsirolimus quality problem: suspected counterfeit product, potentially contaminated product indicated by suspicious odor or unusual color, inaccurate or unreadable product labeling
  • Potential Temsirolimus use error: mixing up products with similar drug names or packaging, taking wrong dose of a drug because of confusing dosing instructions on label
  • When applicable, Problems with different manufacturer of same medicine: not getting same results from a generic drug as a brand name drug, or from another generic

side effects
Temsirolimus Side Effects Notice - The material on this site is for informational purposes only, and is not a substitute for medical advice, diagnosis or treatment provided by a qualified health care provider. PatientsVille.com does not provide medical advice, diagnosis or treatment. The information regarding Temsirolimus adverse reports, reviews and polls contained on PatientsVille.com site has not been scientifically or otherwise verified as to a cause and effect relationship and cannot be used to estimate the incidence of adverse drug reactions or for establishing or changing of patient treatments. Thank you for visiting Patientsville.com!